2-(7-Methoxynaphthalen-1-yl)Acetic Acid

We are 2-(7-Methoxynaphthalen-1-yl)Acetic Acid CAS:6836-22-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  2-(7-Methoxynaphthalen-1-yl)Acetic Acid
CAS.NO:6836-22-2
Synonyms:
2-(7-Methoxynaphthalen-1-yl)acetic acid

Molecular Formula: C13H12O3
Molecular Weight: 216.23300

Physical and Chemical Properties:
Density: 1.235
Boiling point: 408.8ºC at 760 mmHg
Melting point: 153-154ºC
Flash point: 160.7ºC
Refractive index: 1.625

Specification:
Appearance: Light yellow powder
Purity:≥99%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:
Intermediates of Agomelatine  CAS:138112-76-2

2-(7-Methoxynaphthalen-1-yl)Acetic Acid


Related News: Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact.1-cloro-5-fluoropentano CAS:407-98-7 Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact.1-[(2R,4S,5S)-4-azido-5-(trityloxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday. 4-bromo-3-fluoroanisol CAS:458-50-4 In these situations, the API is not a single substance but the culmination of various ingredients.Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2).

Related Products
Product Name
4-(4-Methoxyphenyl)morpholine View Details
(2R,3S)-N-Boc-3-Phenylisoserine View Details
2-Anilinoethanol View Details
p-Nitrophenyl 2-(Furfurylsulfinyl)acetate manufacturer 5-Bromo-2-fluorotoluene manufacturer ethyl 2-amino-1,3-thiazole-5-carboxylate manufacturer 1,10-Dibromodecane manufacturer 1-chloro-7-iodoheptane manufacturer